Crossmark

Current treatment practices for anemia in patients with chronic kidney disease and future opportunities with hypoxia-inducible factor prolyl hydroxylase inhibitors: a narrative review

Crossref DOI link: https://doi.org/10.1007/s11255-020-02584-x

Published Online: 2020-08-08

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kile, Mercedes

Sudchada, Patcharaporn https://orcid.org/0000-0001-8327-4282
License Information

Text and Data Mining valid from 2020-08-08

Version of Record valid from 2020-08-08
More Information

Article History

Received: 24 December 2019

Accepted: 25 July 2020

First Online: 8 August 2020

Compliance with ethical standards

:

: The authors (PS and MK) declare that they have no potential conflict of interest regarding the publication of the paper.

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below